Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference
Kiniksa Pharmaceuticals (Nasdaq: KNSA) announced management will participate in a fireside chat at the TD Cowen 46th Annual Health Care Conference on March 2, 2026 at 3:10 p.m. ET.
Rhea-AI Summary
Kiniksa Pharmaceuticals (Nasdaq: KNSA) announced management will participate in a fireside chat at the TD Cowen 46th Annual Health Care Conference on March 2, 2026 at 3:10 p.m. ET. A live webcast will be available via the Investors section of Kiniksa's website, with a replay posted within approximately 48 hours.
Details
News Market Reaction – KNSA
On Feb 26, the first trading day after this news, KNSA closed 1.71% above the previous close.
Data tracked by StockTitan Argus for the Feb 26 session.
Key Figures
- Conference date
- March 2, 2026
- TD Cowen 46th Annual Health Care Conference fireside chat
- Presentation time
- 3:10 p.m. Eastern Time
- Scheduled start time for Kiniksa fireside chat
- Replay availability
- Within approximately 48 hours
- Replay posted to company website after the event
Historical Context
-
Strong 2025 ARCALYST growth and profitability with 2026 revenue outlook.
-
Announcement of scheduled Q4 and full-year 2025 results call.
-
Unaudited 2025 ARCALYST revenue, growth metrics, and pipeline milestones.
-
J.P. Morgan Healthcare Conference appearance and webcast details.
-
Jefferies Global Healthcare Conference presentation and webcast access.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LONDON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026 at 3:10 p.m. Eastern Time.
A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.
About Kiniksa
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit www.kiniksa.com.
Every Second Counts! ®
Kiniksa Investor & Media Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.